
India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 age group, subject to certain conditions, on March 9.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CE7ywTk
via
IFTTT
0 comments:
Post a Comment